New Tavist offering
This article was originally published in The Tan Sheet
Executive Summary
Novartis Tavist NightTime Allergy provides "relief from sinus & nasal congestion, runny nose & sneezing" with an antihistamine "so you can rest," product labeling says. Line extension, which began hitting shelves in March, contains diphenhydramine 25 mg as an antihistamine, pseudoephedrine 60 mg as a nasal decongestant and is the only OTC positioned primarily for relief of nighttime allergy symptoms, Novartis says. Available in 24- and 48-count caplets for between $3.99 and $6.99, NightTime Allergy is the Tavist line's fourth offering. Product, which was originally named Tavist D/A, was slated to debut a year ago (1"The Tan Sheet" March 5, 2001, p. 5)...
You may also be interested in...
Tavist Line Extensions Include NDA, Monograph Products
Novartis Consumer Health is now shipping Tavist Allergy/Sinus/Headache following FDA approval of the firm's new drug application March 1.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.